Covered recipient · General Payments record
STACEY E GALLAS
Allopathic & Osteopathic Physicians Pediatrics
General Payments · PY2018–2024
$1,307.84
- Reported across 54 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $299.36 | 15 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Corium, Inc. | $101.01 | 4 |
| Supernus Pharmaceuticals, Inc. | $50.01 | 3 |
| PFIZER INC. | $45.64 | 2 |
| ALK-Abello, Inc | $31.94 | 2 |
| Acerta Pharma LLC | $23.34 | 1 |
| PhotoniCare Inc | $18.69 | 1 |
| Merck Sharp & Dohme Corporation | $14.64 | 1 |
| Cranial Technologies, Inc | $14.09 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (15)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ALK-Abello, Inc | $16.43 | 05/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1099890821 | CMS |
| ALK-Abello, Inc | $15.51 | 08/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1099890819 | CMS |
| AstraZeneca Pharmaceuticals LP | $23.34 | 11/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104304202 | CMS |
| Corium, LLC | $27.28 | 07/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100196232 | CMS |
| Corium, LLC | $28.07 | 09/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100197560 | CMS |
| Corium, LLC | $18.37 | 11/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100173090 | CMS |
| Corium, LLC | $27.29 | 11/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100196270 | CMS |
| Cranial Technologies, Inc | $14.09 | 03/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1082232574 | CMS |
| Merck Sharp & Dohme LLC | $14.64 | 08/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1141953471 | CMS |
| PFIZER INC. | $23.90 | 05/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131507016 | CMS |
| PFIZER INC. | $21.74 | 10/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1130880410 | CMS |
| PhotoniCare Inc | $18.69 | 09/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1081237950 | CMS |
| Supernus Pharmaceuticals, Inc. | $16.70 | 01/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1147850367 | CMS |
| Supernus Pharmaceuticals, Inc. | $14.62 | 02/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1147850365 | CMS |
| Supernus Pharmaceuticals, Inc. | $18.69 | 12/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1147898132 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.